-
1.NOVEL LIPID NANOPARTICLES AND NOVEL COMPONENTS FOR DELIVERY OF NUCLEIC ACIDS 审中-公开
标题翻译: 新脂质纳米粒的新组件发布的NUCLEIC公开(公告)号:EP2326331A1
公开(公告)日:2011-06-01
申请号:EP09808606.9
申请日:2009-08-11
发明人: BOWMAN, Keith, A. , GUARE, James, P. , HARTMAN, George, D. , PARMAR, Rubina, G. , VARGEESE, Chandra , WANG, Weimin , ZHANG, Ye
IPC分类号: A61K31/56
CPC分类号: A61K9/5123 , A61K9/1272 , A61K9/1277 , A61K9/5192 , A61K47/28 , C07C217/42
摘要: The instant invention provides for novel lipid nanoparticles and novel lipid nanoparticle components (specifically cationic lipids) that are useful for the delivery of nucleic acids, specifically siRNA, for therapeutic purposes.
-
公开(公告)号:EP1729772B1
公开(公告)日:2016-12-07
申请号:EP05726105.9
申请日:2005-03-23
发明人: BLACKABY, Wesley , DUGGAN, Mark, E. , HALLETT, David , HARTMAN, George, D. , JENNINGS, Andrew, S. , LEISTER, William, H. , LEWIS, Richard, T. , LINDSLEY, Craig, W. , NAYLOR, Elizabeth , STREET, Leslie, J. , WANG, Yi , WISNOSKI, David, D. , WOLKENBERG, Scott, E. , ZHAO, Zhijian
IPC分类号: C07D409/14 , C07D401/14 , C07D413/14 , C07D401/04
CPC分类号: C07D409/14 , C07D401/04 , C07D401/14 , C07D413/14
-
公开(公告)号:EP1729772B8
公开(公告)日:2017-04-19
申请号:EP05726105.9
申请日:2005-03-23
发明人: BLACKABY, Wesley , DUGGAN, Mark, E. , HALLETT, David , HARTMAN, George, D. , JENNINGS, Andrew, S. , LEISTER, William, H. , LEWIS, Richard, T. , LINDSLEY, Craig, W. , NAYLOR, Elizabeth , STREET, Leslie, J. , WANG, Yi , WISNOSKI, David, D. , WOLKENBERG, Scott, E. , ZHAO, Zhijian
IPC分类号: C07D409/14 , C07D401/14 , C07D413/14 , C07D401/04
CPC分类号: C07D409/14 , C07D401/04 , C07D401/14 , C07D413/14
-
公开(公告)号:EP1765830B1
公开(公告)日:2010-09-22
申请号:EP05786157.7
申请日:2005-06-27
发明人: BERGMAN, Jeffrey, M. , COLEMAN, Paul, J. , FRALEY, Mark, E. , GARBACCIO, Robert, M. , HARTMAN, George, D. , LI, Chunze , NEILSON, Lou Anne , OLSON, Christy, M. , TASBER, Edward, S.
IPC分类号: C07D498/04 , C07D519/00 , A61K31/5383 , A61P35/00
CPC分类号: C07D498/04 , C07D519/00
摘要: The present invention relates to tricyclic pyrazoles according to Formula (I) that are useful for treating cellular proliferative diseases, for treating disorders associated with KSP kinesin activity, and for inhibiting KSP kinesin. The invention also relates to compositions which comprise these compounds, and methods of using them to treat cancer in mammals.
摘要翻译: 本发明涉及根据式(I)的三环吡唑,其可用于治疗细胞增殖性疾病,用于治疗与KSP驱动蛋白活性相关的病症和用于抑制KSP驱动蛋白。 本发明还涉及包含这些化合物的组合物,以及使用它们治疗哺乳动物癌症的方法。
-
-
-